Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the effects of inflammation-lowering
therapy on mobility and disability in older adults. The main questions it aims to answer are:
- Will therapy improve walking speed/pace?
- Will therapy improve levels of blood inflammation markers and other indicators of
physical, cognitive and immune function?
Participants will be asked to receive injections of drug or placebo every 4 weeks for 24
weeks. They will also be asked to undergo testing that assesses physical function, thinking
ability and brain health, breathing capacity, and blood vessel stiffness, and will have blood
samples collected to measure immune function and to create a bank of samples for future
testing. Comparisons will be made between those who receive drug and those who receive
placebo.